<DOC>
	<DOCNO>NCT01786122</DOCNO>
	<brief_summary>AIM : To evaluate effectiveness efficiency innovative exercise program ( EP ) patient treatment gastrointestinal tumor , breast non small cell lung cancer , term improve quality life ( QOL ) , fatigue functional capacity respect usual standard treatment ( ST ) . DESIGN : Pragmatic randomize clinical trial two parallel group : EP ST . SETTING : 7 Primary Health Centers ( PHC ) redIAPPISCIII , coordination oncology service . PARTICIPANTS : 250 patient tumor , locally advanced metastatic disease , adjuvant treatment , Performance Status ( PS ) PS1-PS0 . INTERVENTION : Both group receive standardized usual care . The EP group receive , addition , nurse supervise exercise program 2 month PHC second phase community facility remain 10 month . MEASUREMENTS : The primary outcome measure change baseline QOL+66 treatment , measure specific questionnaire patient cancer EORTC QLQ-C-30 Short Form ( SF-36 ) overall . Secondary : fatigue ( FACIT-F ) , radiological response , functional capacity ( 6 minute walk cardiopulmonary test ) , muscle strength progression-free survival overall . Predictors confounders : age , sex , stage tumor type , histology , treatment . ANALYSIS : We compare group mean change baseline measurement quality life questionnaire ( QOL ) variable , intention treat basis , use longitudinal mixed-effects model repeat measure 2 , 6 12 month follow-up . Cost / effectiveness cost / incremental utility associate program wil estimate .</brief_summary>
	<brief_title>Clinical Trial : Effectiveness Efficiency Physical Exercise Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Digestive System Neoplasms</mesh_term>
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<criteria>Age 1870 year Diagnosis digestive system cancer , breast cancer histologically confirm NSCLC stage IV Physical Status ( PS ) 0 1 . Firstline chemotherapy treatment type standard tumor Adequate renal , liver blood function . Brain metastasis Risk fracture ( bone metastasis ) Unstable heart disease , uncontrolled BP Systolic Blood Pressure ( ( SBP ) &gt; 200 Diastolic Blood Pressure ( DBP ) &gt; 110 ) , heart failure ( NYHA II great ) , constrictive pericarditis Other disease discretion investigator contraindication physical exercise . Perform regular physical activity ( 150 minute / week moderate vigorous 75 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>physical exercise</keyword>
	<keyword>Health Related Quality Life</keyword>
	<keyword>Non-Small-Cell Lung Carcinoma</keyword>
	<keyword>digestive system neoplasm</keyword>
	<keyword>breast neoplasm</keyword>
</DOC>